BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 22949430)

  • 1. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
    Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
    Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
    Ho CY; Carlsen C; Thune JJ; Havndrup O; Bundgaard H; Farrohi F; Rivero J; Cirino AL; Andersen PS; Christiansen M; Maron BJ; Orav EJ; Køber L
    Circ Cardiovasc Genet; 2009 Aug; 2(4):314-21. PubMed ID: 20031602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study.
    Ho CY; Day SM; Colan SD; Russell MW; Towbin JA; Sherrid MV; Canter CE; Jefferies JL; Murphy AM; Cirino AL; Abraham TP; Taylor M; Mestroni L; Bluemke DA; Jarolim P; Shi L; Sleeper LA; Seidman CE; Orav EJ;
    JAMA Cardiol; 2017 Apr; 2(4):419-428. PubMed ID: 28241245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.
    Groarke JD; Galazka PZ; Cirino AL; Lakdawala NK; Thune JJ; Bundgaard H; Orav EJ; Levine RA; Ho CY
    Eur Heart J Cardiovasc Imaging; 2018 Oct; 19(10):1109-1116. PubMed ID: 30052928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
    Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Ventricular Strain Is Abnormal in Preclinical and Overt Hypertrophic Cardiomyopathy: Cardiac MR Feature Tracking.
    Vigneault DM; Yang E; Jensen PJ; Tee MW; Farhad H; Chu L; Noble JA; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Ho CY; Bluemke DA
    Radiology; 2019 Mar; 290(3):640-648. PubMed ID: 30561279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.
    Negri F; Sanna GD; Di Giovanna G; Cittar M; Grilli G; De Luca A; Dal Ferro M; Baracchini N; Burelli M; Paldino A; Del Franco A; Pradella S; Todiere G; Olivotto I; Imazio M; Sinagra G; Merlo M
    Circ Cardiovasc Imaging; 2024 Apr; 17(4):e016042. PubMed ID: 38563190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
    Lakdawala NK; Dellefave L; Redwood CS; Sparks E; Cirino AL; Depalma S; Colan SD; Funke B; Zimmerman RS; Robinson P; Watkins H; Seidman CE; Seidman JG; McNally EM; Ho CY
    J Am Coll Cardiol; 2010 Jan; 55(4):320-9. PubMed ID: 20117437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
    Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile dysfunction irrespective of the mutant protein in human hypertrophic cardiomyopathy with normal systolic function.
    van Dijk SJ; Paalberends ER; Najafi A; Michels M; Sadayappan S; Carrier L; Boontje NM; Kuster DW; van Slegtenhorst M; Dooijes D; dos Remedios C; ten Cate FJ; Stienen GJ; van der Velden J
    Circ Heart Fail; 2012 Jan; 5(1):36-46. PubMed ID: 22178992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
    Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.
    Ho CY; Lakdawala NK; Cirino AL; Lipshultz SE; Sparks E; Abbasi SA; Kwong RY; Antman EM; Semsarian C; González A; López B; Diez J; Orav EJ; Colan SD; Seidman CE
    JACC Heart Fail; 2015 Feb; 3(2):180-8. PubMed ID: 25543971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.
    Kamisago M; Sharma SD; DePalma SR; Solomon S; Sharma P; McDonough B; Smoot L; Mullen MP; Woolf PK; Wigle ED; Seidman JG; Seidman CE
    N Engl J Med; 2000 Dec; 343(23):1688-96. PubMed ID: 11106718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].
    Ho CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):289-93. PubMed ID: 19791460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations in genes for sarcomeric proteins].
    Kimura A
    Nihon Rinsho; 2000 Jan; 58(1):117-22. PubMed ID: 10885298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
    Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
    J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left ventricular diastolic reserve during acute pressure loading in hypertrophic cardiomyopathy and dilated cardiomyopathy].
    Yokote Y; Okamoto M; Sakura E; Shimamoto H; Amioka H; Yamagata T; Hashimoto M; Tsuchioka Y; Matsuura H; Kajiyama G
    J Cardiol; 1988 Dec; 18(4):1051-60. PubMed ID: 3267714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and genetic characteristics of different types of non-obstructive hypertrophic cardiomyopathy].
    Zhang M; Sun XL; Wu GX; Wang D; Wang LM; Wang JZ; Kang LM; Song L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jun; 49(6):593-600. PubMed ID: 34126727
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy.
    Puckelwartz MJ; Pesce LL; Dellefave-Castillo LM; Wheeler MT; Pottinger TD; Robinson AC; Kearns SD; Gacita AM; Schoppen ZJ; Pan W; Kim G; Wilcox JE; Anderson AS; Ashley EA; Day SM; Cappola T; Dorn GW; McNally EM
    J Am Heart Assoc; 2021 Apr; 10(7):e019944. PubMed ID: 33764162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.